Patents Represented by Attorney OPKO CuRNA, LLC

Find this attorney in the Justia Lawyer Directory

  • Treatment of apolipoprotein-A1 related diseases by inhibition of natural antisense transcript to apolipoprotein-A1
    Patent number: 8153606
    Abstract: Oligonucleotide compounds modulate expression and/or function of an apolipoprotein (ApoA1) polynucleotides and encoded products thereof. Methods for treating diseases associated with apolipoprotein-A1 (ApoA1) comprise administering one or more Oligonucleotide compounds designed to inhibit the Apo-A1 natural antisense transcript to patients.
    Type: Grant
    Filed: October 2, 2009
    Date of Patent: April 10, 2012
    Assignee: OPKO CuRNA, LLC
    Inventors: Joseph Collard, Olga Khorkova